Pictet-Biotech I dy GBP
Category Sector Equity Biotechnology
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£824.02
£-4.20 (-0.51%)
Fund Code
PIBTI
B554RF5
LU0448836352
Prices updated as at 17 Apr 2024
Prices in GBP
Investment objective
This Compartment applies a capital growth strategy by investing at least two-thirds of its total assets/total wealth in equities or similar securities issued by biopharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments will be made in these regions. To capitalise on particularly innovative projects in the pharmaceuticals field, the Biotech Compartment may invest up to 10% of its net assets in Private Equity and/or unlisted securities.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
| Fund status | Open |
| Fund type | SICAV |
| Fund manager | Tazio Storni, Marco Minonne, Lydia Haueter, Eugénio Martin-Fougeroux |
| 930.88 | |
| 661.56 | |
| Fund comparative index | MSCI ACWI NR EUR |
| Specialist | |
| - | |
| 1.10 | |
| 0.16 | |
| 0.00 | |
| Sector Equity Biotechnology | |
| No | |
| Fund provider | Pictet Asset Management (Europe) SA |
| Share class launch date | 10 Sep 2009 |
| £1.23b | |
| - | |
| 0.00 | |
| - | |
| Annually |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
